• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Total number of clinical trials

  • Expand All
  • Collapse All
  • Pages
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • expand A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects with Moderate to Severe Hidradenitis Suppurativa
    Study Id
    D5440C00001
    Disease
    safety, skin disease
    Drug Name
    MEDI8968
    Study Name
    D5440C00001
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Multicentre, Open-label, Randomized, 6-week, Phase IV Study of the Onset and Maintenance of the Antiplatelet Effect of Ticagrelor Compared with Clopidogrel with Aspirin as Background Therapy in Chinese Patients with Non-ST or ST Elevation Acute Coronary Syndromes (ACS)
    Study Id
    D5130L00053
    Disease
    acute coronary syndrome
    Drug Name
    Brilinta
    Study Name
    D5130L00053
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Post Marketing Surveillance to evaluate the safety and efficacy of Brilinta
    Study Id
    D5130L00019
    Disease
    acute coronary syndrome, myocardial infarction, unstable angina pectoris
    Drug Name
    Brilinta
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Clinical study assessing the safety, tolerability, and pharmacokinetics of intravenous AZD5099 in health subjects
    Study Id
    D0910C00015
    Disease
    infection
    Drug Name
    AZD5099
    Study Name
    D0910C00015
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report
    Jun 18, 2012
    • D0910C00015.pdf (143 KB)
  • expand The asthma control rate achieved by budesonide/formoterol in clinical practice in China
    Study Id
    NIS-RCN-SYM-2012/1
    Disease
    asthma
    Drug Name
    non drug study (respiratory)
    Study Name
    NIS-RCN-SYM-2012/1
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Dapagliflozin Effect on Cardiovascular Events A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients with Type 2 Diabetes
    Study Id
    D1693C00001
    Disease
    myocardial infarction
    Drug Name
    dapagliflozin
    Study Name
    D1693C00001
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A cohort study with a nested case control analysis on the association between acid-suppressing drugs and seizures using THIN database in the UK.
    Study Id
    D9612N00017
    Disease
    epidemiology
    Drug Name
    non drug study (gastrointestinal)
    Study Name
    D9612N00017
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Nexium capsules Clinical Experience Investigation
    Study Id
    D961HC00010
    Disease
    gastroenterology
    Drug Name
    Nexium, esomeprazole
    Study Name
    D961HC00010
    Recruiting Status
    Open
    Protocol
    Apr 29, 2013
    • D961HC00010 (240 KB)
    Report Status
    Not Available
  • expand A Phase III, Multicentre, Randomised, Double-Blind, Comparative Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia
    Study Id
    D3720C00002
    Disease
    bacterial infection
    Study Name
    D3720C00002
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Nexium capsules Specific Clinical Experience Investigation for long-term use concerning prevention of recurrence of gastric ulcer or duodenal ulcer with LDA
    Study Id
    D961PC00002
    Disease
    duodenal ulcer, gastric ulcer
    Drug Name
    AstraZeneca Gastrointestinal Brands
    Study Name
    NIS-GJP-NEX-2012/1
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • Pages
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • Expand All
  • Collapse All

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013